These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10728492)

  • 21. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
    Halonen T; Nissinen J; Jansen JA; Pitkänen A
    Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic tiagabine treatment on [3H]GABAA, [3H]GABAB and [3H]tiagabine binding to sections from mice brain.
    Thomsen C; Suzdak PD
    Epilepsy Res; 1995 Jun; 21(2):79-88. PubMed ID: 7588591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative autoradiographic characterization of the binding of [3H]tiagabine (NNC 05-328) to the GABA uptake carrier.
    Suzdak PD; Foged C; Andersen KE
    Brain Res; 1994 Jun; 647(2):231-41. PubMed ID: 7922499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes.
    Leach JP; Sills GJ; Majid A; Butler E; Carswell A; Thompson GG; Brodie MJ
    Seizure; 1996 Sep; 5(3):229-34. PubMed ID: 8902926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat.
    Van Sassenbroeck DK; De Paepe P; Belpaire FM; Rosseel MT; Martens P; Boon PA; Buylaert WA
    J Pharm Pharmacol; 2001 Dec; 53(12):1687-96. PubMed ID: 11804399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of interaction between tiagabine, a new antiepileptic drug, and the benzodiazepine triazolam.
    Richens A; Marshall RW; Dirach J; Jansen JA; Snel S; Pedersen PC
    Drug Metabol Drug Interact; 1998; 14(3):159-77. PubMed ID: 10366992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.
    Fink-Jensen A; Suzdak PD; Swedberg MD; Judge ME; Hansen L; Nielsen PG
    Eur J Pharmacol; 1992 Sep; 220(2-3):197-201. PubMed ID: 1425991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus.
    Inglefield JR; Perry JM; Schwartz RD
    Hippocampus; 1995; 5(5):460-8. PubMed ID: 8773258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.
    Dalby NO
    Neuropharmacology; 2000 Sep; 39(12):2399-407. PubMed ID: 10974324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity-dependent enhancement of hyperpolarizing and depolarizing gamma-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine.
    Jackson MF; Esplin B; Capek R
    Epilepsy Res; 1999 Oct; 37(1):25-36. PubMed ID: 10515172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
    Walton NY; Gunawan S; Treiman DM
    Epilepsy Res; 1994 Dec; 19(3):237-44. PubMed ID: 7698100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory nature of tiagabine-augmented GABAA receptor-mediated depolarizing responses in hippocampal pyramidal cells.
    Jackson MF; Esplin B; Capek R
    J Neurophysiol; 1999 Mar; 81(3):1192-8. PubMed ID: 10085346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological indirect effect modeling of the antilipolytic effects of adenosine A1-receptor agonists.
    van Schaick EA; de Greef HJ; Ijzerman AP; Danhof M
    J Pharmacokinet Biopharm; 1997 Dec; 25(6):673-94. PubMed ID: 9697077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses.
    Gustavson LE; Mengel HB
    Epilepsia; 1995 Jun; 36(6):605-11. PubMed ID: 7555975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze.
    Schmitt U; Hiemke C
    Behav Brain Res; 2002 Jul; 133(2):391-4. PubMed ID: 12110474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.